Patents by Inventor Kyung Sil YOON

Kyung Sil YOON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phosphine precursor for preparing quantum dot and quantum dot prepared therefrom
    Patent number: 11999762
    Abstract: The present invention relates to a phosphine precursor for the preparation of a quantum dot, and a quantum dot prepared therefrom. Using the phosphine precursor for the preparation of a quantum dot of the present invention, a quantum dot with improved luminous efficiency and higher luminous color purity can be provided.
    Type: Grant
    Filed: April 7, 2022
    Date of Patent: June 4, 2024
    Assignee: SK Chemicals Co., Ltd.
    Inventors: Jeong Ho Park, Hee Il Chae, Kyung Sil Yoon, Ju-Sik Kang, Yu Mi Chang, Nam-Choul Yang, Jae Kyun Park, Song Lee
  • Phosphine precursor for preparing quantum dot and quantum dot prepared therefrom
    Patent number: 11912915
    Abstract: The present invention relates to a phosphine precursor for the preparation of a quantum dot, and a quantum dot prepared therefrom. Using the phosphine precursor for the preparation of a quantum dot of the present invention, a quantum dot with improved luminous efficiency and higher luminous color purity can be provided.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: February 27, 2024
    Assignee: SK Chemicals Co., Ltd.
    Inventors: Hee Il Chae, Jeong Ho Park, Kyung Sil Yoon, Ju-Sik Kang, Yu Mi Chang, Nam-Choul Yang, Jae Kyun Park, Song Lee
  • COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER, COMPRISING A COMPOUND ISOLATED FROM CEPHALOTAXUS EXTRACT AS AN ACTIVE INGREDIENT
    Publication number: 20240058405
    Abstract: The present disclosure relates to a composition for preventing or treating lung cancer, comprising a compound isolated from a Cephalotaxus extract as an active ingredient. Isoharringtonine, which is the compound isolated from the Cephalotaxus extract according to the present disclosure, induces apoptosis and exhibits the effect of inhibiting the growth of non-small cell lung cancer cell lines, and thus can be useful in the prevention or treatment of lung cancer. In addition, the combined treatment of isoharringtonine and siNR4A1 enhances anticancer activity, and the combined treatment of isoharringtonine and cisplatin, which is a conventional anticancer drug, induces a high anticancer effect at a low concentration of cisplatin, thereby reducing side effects of anticancer treatment.
    Type: Application
    Filed: October 5, 2021
    Publication date: February 22, 2024
    Applicants: NATIONAL CANCER CENTER, NATIONAL INSTITUTE FOR KOREAN MEDICINE DEVELOPMENT
    Inventors: Kyung Sil YOON, Yong Nyun KIM, Jae Gal SHIM, Dong Hoon SHIN, Hyo Jung KIM, Myoung Lae CHO, Soo Hyun KIM
  • PHOSPHINE PRECURSOR FOR PREPARING QUANTUM DOT AND QUANTUM DOT PREPARED THEREFROM
    Publication number: 20220235077
    Abstract: The present invention relates to a phosphine precursor for the preparation of a quantum dot, and a quantum dot prepared therefrom. Using the phosphine precursor for the preparation of a quantum dot of the present invention, a quantum dot with improved luminous efficiency and higher luminous color purity can be provided.
    Type: Application
    Filed: April 7, 2022
    Publication date: July 28, 2022
    Inventors: Jeong Ho PARK, Hee IL CHAE, Kyung Sil YOON, Ju-Sik KANG, Yu Mi CHANG, Nam-Choul YANG, Jae Kyun PARK, Song LEE
  • METHOD FOR PREPARING 3(4),8(9)-BISFORMYLTRICYCLO[5.2.1.0^2,6]DECANE
    Publication number: 20210253507
    Abstract: A method of preparing 3(4),8(9)-bisformyltricyclo[5.2.1.02,6]decane is provided. According to the present invention, 3(4),8(9)-bisformyltricyclo[5.2.1.02,6]decane (TCDDA) may be prepared with a high conversion rate and purity without a separate catalyst recovery process.
    Type: Application
    Filed: May 31, 2019
    Publication date: August 19, 2021
    Inventors: Hee IL CHAE, Jeong Ho PARK, Kyung Sil YOON, Ju-Sik KANG, Yu Mi CHANG, Nam-Choul YANG, Jae Kyun PARK, Song LEE
  • PHOSPHINE PRECURSOR FOR PREPARING QUANTUM DOT AND QUANTUM DOT PREPARED THEREFROM
    Publication number: 20200140467
    Abstract: The present invention relates to a phosphine precursor for the preparation of a quantum dot, and a quantum dot prepared therefrom. Using the phosphine precursor for the preparation of a quantum dot of the present invention, a quantum dot with improved luminous efficiency and higher luminous color purity can be provided.
    Type: Application
    Filed: May 16, 2018
    Publication date: May 7, 2020
    Inventors: Jeong Ho PARK, Hee IL CHAE, Kyung Sil YOON, Ju-Sik KANG, Yu Mi CHANG, Nam-Choul YANG, Jae Kyun PARK, Song LEE
  • PHOSPHINE PRECURSOR FOR PREPARING QUANTUM DOT AND QUANTUM DOT PREPARED THEREFROM
    Publication number: 20200071608
    Abstract: The present invention relates to a phosphine precursor for the preparation of a quantum dot, and a quantum dot prepared therefrom. Using the phosphine precursor for the preparation of a quantum dot of the present invention, a quantum dot with improved luminous efficiency and higher luminous color purity can be provided.
    Type: Application
    Filed: March 2, 2018
    Publication date: March 5, 2020
    Inventors: Hee IL CHAE, Jeong Ho PARK, Kyung Sil YOON, Ju-Sik KANG, Yu Mi CHANG, Nam-choul YANG, Jae Kyun PARK, Song LEE